These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1274972)

  • 21. Compatibility of netilmicin sulfate injection with commonly used intravenous injections and additives.
    Chaudry IA; Bruey KP; Hurlburt LE; Oden EM
    Am J Hosp Pharm; 1981 Nov; 38(11):1737-42. PubMed ID: 7304628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Particulate evaluation of parenteral nutrition solutions by electronic particle counting and scanning electron microscopy.
    Akers MJ; Schrank GD; Russell S
    Am J Hosp Pharm; 1981 Sep; 38(9):1304-7. PubMed ID: 6792911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Filtering effectiveness of conventional 15 m micron filters (DIN 58362) and newly developed 15 m micron and 5 m micron filters. I: Particle count].
    Walpot H; Franke RP; Burchard WG; Agternkamp C; Müller FG; Mittermayer C; Kalff G
    Infusionstherapie; 1989 Apr; 16(2):77-80. PubMed ID: 2737765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Particle-induced coronary vasoconstriction during cardioplegic infusion. Characterization and possible mechanisms.
    Hearse DJ; Erol C; Robinson LA; Maxwell MP; Braimbridge MV
    J Thorac Cardiovasc Surg; 1985 Mar; 89(3):428-38. PubMed ID: 3974278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial endotoxin retention by inline intravenous filters.
    Baumgartner TG; Schmidt GL; Thakker KM; Sitren HS; Cerda JJ; Mahaffey SM; Copeland EM
    Am J Hosp Pharm; 1986 Mar; 43(3):681-4. PubMed ID: 3518429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbiologic quality assurance for intravenous admixtures in a small hospital.
    Doss HL; James JD; Killough DM; Snodgrass GL
    Am J Hosp Pharm; 1982 May; 39(5):832-5. PubMed ID: 6805321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of inline filtration on the potency of low-dose drugs.
    Butler DL; Munson JM; DeLuca PP
    Am J Hosp Pharm; 1980 Jul; 37(7):935-41. PubMed ID: 7395887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous solutions.
    Cheung YW; Cradock JC; Vishnuvajjala BR; Flora KP
    Am J Hosp Pharm; 1987 Jan; 44(1):124-30. PubMed ID: 3548341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin sodium versus 0.9% sodium chloride injection for maintaining patency of indwelling intermittent infusion devices.
    Hamilton RA; Plis JM; Clay C; Sylvan L
    Clin Pharm; 1988 Jun; 7(6):439-43. PubMed ID: 3402178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of pibenzimol hydrochloride in commonly used infusion solutions and after filtration.
    Toledo MM; Cadwallader DE; Trissel LA; Flora KP
    Am J Hosp Pharm; 1989 Oct; 46(10):2043-6. PubMed ID: 2479268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth of bacteria in intravenous fluids under stimulated actual-use conditions.
    Hugbo PG; Imhanlahimi WA
    Am J Hosp Pharm; 1983 Jun; 40(6):998-1001. PubMed ID: 6408922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association of potassium chloride and particulate matter with the development of phlebitis.
    Ervin SM
    NITA; 1987; 10(2):145-9. PubMed ID: 3645345
    [No Abstract]   [Full Text] [Related]  

  • 33. Stability of cisplatin and etoposide in intravenous admixtures.
    Stewart CF; Hampton EM
    Am J Hosp Pharm; 1989 Jul; 46(7):1400-4. PubMed ID: 2757048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of methods for detection of particulate matter in large-volume perenterals.
    Blanchard J; Thompson CM; Schwartz JA
    Am J Hosp Pharm; 1976 Feb; 33(2):144-50. PubMed ID: 1258874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Letter: Particulate matter in penicillin G potassium injection.
    Turco SJ; Davis NM; Bhatia R
    Am J Hosp Pharm; 1974 Sep; 31(9):825-6. PubMed ID: 4420020
    [No Abstract]   [Full Text] [Related]  

  • 36. Stability and availability of cyclosporine in 5% dextrose injection or 0.9% sodium chloride injection.
    Ptachcinski RJ; Logue LW; Burckart GJ; Venkataramanan R
    Am J Hosp Pharm; 1986 Jan; 43(1):94-7. PubMed ID: 3953588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Particulate-matter content of 11 cephalosporin injections: conformance with USP limits.
    Parkins DA; Taylor AJ
    Am J Hosp Pharm; 1987 May; 44(5):1111-8. PubMed ID: 3605122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Particulate and microbial contamination in in-use admixed intravenous infusions.
    Yorioka K; Oie S; Oomaki M; Imamura A; Kamiya A
    Biol Pharm Bull; 2006 Nov; 29(11):2321-3. PubMed ID: 17077539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Final inline filtration: a means of decreasing the incidence of infusion phlebitis.
    Bivins BA; Rapp RP; DeLuca PP; McKean H; Griffen WO
    Surgery; 1979 Apr; 85(4):388-94. PubMed ID: 432800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of oral electrolytes in the management of acute gastroenteritis in non-hospitalised children.
    Santhanakrishnan BR; Deenadayulu K; Raju VB
    Indian Pediatr; 1974 May; 11(5):351-4. PubMed ID: 4426662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.